The psychedelic drugs market is experiencing a resurgence in interest and applications, primarily in the field of mental health and therapy. Psychedelics, such as psilocybin and MDMA, are being explored for their potential to treat depression, anxiety, PTSD, and addiction. The dominating segment within this market is psychedelic-assisted therapy, where these substances are used in conjunction with therapeutic practices to address various mental health conditions. This holistic approach shows promise in revolutionizing mental healthcare and promoting overall well-being.
Access Full Report at https://www.databridgemarketresearch.com/reports/us-psychedelic-drugs-market
Data Bridge Market Research analyses that the U.S. Psychedelic Drugs Market was valued at USD 2,834.72 million in 2021 and is expected to reach USD 9,818.68 million by 2029, registering a CAGR of 16.8% during the forecast period of 2022 to 2029. The rising incidence of mental health conditions such as depression and PTSD has intensified the demand for innovative treatment approaches. Conventional treatments often have limitations, prompting the search for novel, more effective options, such as psychedelic-assisted therapies, to address the growing mental health crisis.
Key Findings of the Study
Regulatory changes are expected to drive the market's growth rate
Evolving regulations signify a notable shift in how psychedelic substances are perceived and studied. These changes enable researchers and scientists to conduct more extensive and rigorous clinical trials involving psychedelics. The relaxation of restrictions has provided an opportunity to explore the therapeutic potential of these substances in treating mental health disorders. This regulatory shift acknowledges the need for innovative solutions and encourages scientific exploration to unlock the promising benefits of psychedelics within a controlled and safe framework.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2022 to 2029
|
Base Year
|
2021
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
Segments Covered
|
Source (Synthetic, Natural), Type (Empathogens, Dissociatives, Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)
|
Countries Covered
|
U.S., Canada and Mexico in North America.
|
Market Players Covered
|
Avadel（愛爾蘭）、Celon Pharma SA（波蘭）、強生私人有限公司（美國）、Hikma Pharmaceuticals PLC（英國）、Amneal Pharmaceuticals LLC。 （美國）、NeuroRx, Inc.（美國）、Jazz Pharmaceuticals, Inc.（愛爾蘭）、COMPASS（英國）、Develco Pharma Schweiz AG（瑞士）、Douglas Pharmaceuticals Limited（紐西蘭）
|
報告涵蓋的數據點
|
除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括深度專家分析、患者流行病學、管道分析、定價分析和監管框架。
|
細分分析：
美國迷幻藥市場根據來源、類型、藥物、應用、給藥途徑、最終用戶和分銷管道進行細分。
- 根據來源，美國迷幻藥市場分為合成和天然。
- 根據類型，美國迷幻藥市場分為同理心、分離劑和其他。
- 根據基礎藥物，美國迷幻藥市場分為γ-羥基丁酸、氯胺酮、裸蓋菇素等。
- 根據應用，美國迷幻藥市場分為發作性睡病、難治性憂鬱症、重度憂鬱症、鴉片類藥物成癮、創傷後壓力症候群等。
- 根據給藥途徑，美國迷幻藥市場分為口服、吸入和注射。
- 根據最終用戶，美國迷幻藥市場分為醫院、專科診所、家庭護理和其他。
- 根據分銷管道，美國迷幻藥市場分為醫院藥房、零售藥房和網路藥房。
主要參與者
Data Bridge Market Research 認為美國迷幻藥市場的主要參與者包括以下公司：Avadel（愛爾蘭）、Celon Pharma SA（波蘭）、強生私人有限公司（美國）、Hikma Pharmaceuticals PLC（英國）、Amneal Pharmaceuticals LLC。 （美國）、NeuroRx, Inc.（美國）、Jazz Pharmaceuticals, Inc.（愛爾蘭）、COMPASS（英國）。
市場發展
- 2020年1月，楊森製藥公司向歐洲藥品管理局提交了SPRAVATO鼻噴劑的II類變更申請。該申請旨在擴大鼻噴劑作為短期急性療法在更廣泛患者中治療憂鬱症症狀的應用。這項策略性舉措旨在擴大產品的市場覆蓋率並可能增加公司的收入。
- 2022 年 10 月，精神保健領域的先驅 Numinus Wellness Inc. 推出了針對慢性和嚴重疾病的氯胺酮計畫。最初，該計劃將在位於猶他州、不列顛哥倫比亞省和魁北克省的 Numinus 診所推廣。該公司計劃在未來幾個月內逐步將該計劃擴展到更多診所，以體現其致力於為患有慢性和嚴重疾病的個人提供創新的、循證的迷幻輔助療法的承諾。
- 2022年3月，加州大學的研究人員揭露了迷幻物質3,4亞甲基二氧基甲基安非他命（MDMA）與心理療法聯合使用治療創傷後壓力症候群（PTSD）的3期臨床試驗的發現和後續資訊。他們的初步數據表明該療法是有效的，即使在具有挑戰性的情況下也是如此，包括有藥物或酒精使用障礙史的患者。這表明這種聯合方法治療 PTSD 具有良好的潛力。
有關美國迷幻藥市場報告的更多詳細信息，請點擊此處 - https://www.databridgemarketresearch.com/reports/us-psychedelic-drugs-market
